Biotech

All Articles

Galapagos' stock up as fund presents intent to form its own progression

.Galapagos is coming under extra stress from investors. Having actually created a 9.9% concern in Ga...

Cell- concentrated Sana scoops first CSO-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our roundup of significant leadership hirings, firings a...

Allist settles Jacobio $21M, landing part in Chinese KRAS race

.Shanghai Allist Pharmaceuticals has acquired on its own a starring role in China's KRAS market, pay...

ReNeuron leaving purpose swap after missing out on fundraising objective

.ReNeuron has actually participated in the lengthy checklist of biotechs to leave behind Greater lon...

MBX files for IPO to take challenger to Ascendis right into phase 3

.MBX Biosciences has actually contributed to the latest spurt of IPO filings. The biotech, which fil...

FDA grows probing right into Lykos' MDMA tests: WSJ

.For Lykos Therapeutics and also the company's would-be MDMA-assisted therapy for post-traumatic str...

Gene editor Tome laying off 131 workers

.Simply times after gene editor Tome Biosciences revealed hidden working slices, a more clear photo ...

Repare lays off 25% of staff as biotech halts preclinical R&ampD

.Repare Therapy is laying off an one-fourth of its own labor force as the oncology biotech scales ba...

J &amp J apply for FDA confirmation of $6.5 B autoimmune medication

.Johnson &amp Johnson has gotten yet another measure toward noticing a return on its $6.5 billion ni...

Gain's period 1 win leads method to confirm Parkinson's medicine's worth

.Gain Therapeutics has actually specified its own direct showing the efficiency of its own Parkinson...